AzTrials
AzTrials

Preoperative AnxietyOpeZenNCT07530120

Effect of 360° VR and 2D Videos on Patient Anxiety in Outpatient Ophthalmologic Care

A study testing Watching a video of the outpatient care pathway and No viewing of the video in people with Preoperative Anxiety and Virtual Reality, run by Institut Ophtalmologique de l'Ouest Jules Verne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Previous research on ambulatory care pathways has highlighted recurring issues such as elevated patient anxiety, disorientation, and insufficient access to information, all of which negatively affect the patient experience. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Preoperative Anxiety, Virtual Reality
What is being tested?
Watching a video of the outpatient care pathway and No viewing of the video
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
180 participants
Where
1 siteFrance
Study dates
1 Oct 2024to 9 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants should be over 18
  • Have all the cognitive and mental abilities
  • Speak french
  • Have a programmated ophthalmology surgery in outpatient
  • Have binocular corrected visual acuity > 5/10 (20/40 Snellen)

Who cannot join

  • Persons referred to in Articles L.1121-6 to L.1121-8 of the French Public Health Code (CSP) (guardianship, trusteeship, legal protection, etc.)
  • Patients undergoing surgery under general anesthesia
  • Patients undergoing emergency surgery
  • Surgery not performed within one month following the preoperative appointment (except for the control group)
  • For the group participating in the VR experiment:
  • Any medical condition preventing immersion in virtual reality (e.g., epilepsy, dizziness/vertigo, psychiatric history, use of medication or substances with psychoactive effects, etc.)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Institut Ophtalmologique de l'Ouest Jules Verne

    Nantes, Loire Atlantique, 44300

Other trials in France

About this study

Official title: Differences Between a 360-VR Video and a 2D-video in Reducing Anxiety in an Ophtalmological Ambulatory Care Pathway

Background Previous research on ambulatory care pathways has highlighted recurring issues such as elevated patient anxiety, disorientation, and insufficient access to information, all of which negatively affect the patient experience. However, evidence remains limited regarding the effectiveness of different preparatory media in mitigating these issues in real-world clinical settings.

Objectives The present study aims to assess whether viewing a video of an outpatient ophthalmologic care pathway prior to the day of surgery-either as a standard 2D video or as a 360° immersive video experienced in virtual reality (VR)-reduces patient anxiety and disorientation compared with a control condition without media support. In addition, the study aims to determine which medium is most effective and to explore methods for assessing anxiety, orientation, and information in ecological clinical settings.

Read the detailed description

Background Previous research on ambulatory care pathways has identified recurring issues such as high patient anxiety, disorientation, and insufficient information, all of which negatively impact the patient experience. However, evidence remains limited regarding how different preparatory media may effectively mitigate these factors in real clinical settings.

Objectives The present study aims to assess whether viewing a video of an outpatient ophthalmologic pathway prior to the day of surgery-either as a conventional 2D video or as a 360° immersive video experienced in virtual reality (VR)-reduces patient anxiety and disorientation compared with a control condition without media support. In addition, the study aims to determine which medium is most effective and to explore how anxiety, orientation, and information can be assessed in ecological clinical settings.

An in-the-wild user study is planned with approximately 180 patients undergoing outpatient ophthalmologic surgery. Participants will be assigned to one of three groups: a control group (no video), a 2D video group, or a 360° VR video group. Preoperative state anxiety will be measured using a Visual Analog Scale for Anxiety (VAS-A) at two time points: baseline (preoperative consultation) and immediately before surgery. The primary outcome will focus on the proportion of patients whose preoperative anxiety is lower than baseline anxiety. Disorientation, perception of signage, and patient information will be assessed using post-operative questionnaires. Secondary outcomes will include perceived anxiety during hospitalization, perceived quality of information, and reported feelings of disorientation during the ambulatory pathway.

Being tested
Watching a video of the outpatient care pathway, No viewing of the video
Keywords
Video 2D, 360° video, Virtual Reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Watching a video of the outpatient care pathwayOther

    Also called 2D-V, VR

    Before surgery, patients watch an informational video explaining the outpatient journey at IOO Jules Verne.

  • No viewing of the videoOther

    Also called Control

    The control group does not view the video and receives only verbal information delivered by the administrative staff.

Study groups in NCT07530120
Study groupRoleWhat they receive
Group Control : NONPlacebo comparatorNON (Baseline): Control condition providing no video to the patients. This is what patients really lived routinely in the ophthalmological ambulatory pathway.
Receives: Other: No viewing of the video
Group Video : 2D-VActive comparatorVideo: NON condition with the watching of a 2D video ~1month before the surgery.
Receives: Other: Watching a video of the outpatient care pathway
Group Virtual Reality : VRActive comparatorVR: NON condition with watching of a 360-VR video corresponding to a 360 video of the ophthalmological ambulatory pathway
Receives: Other: Watching a video of the outpatient care pathway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients with reduced preoperative anxiety compared to baseline

    The proportion of patients whose preoperative state anxiety (measured immediately before surgery using a Visual Analog Scale for Anxiety [VAS-A]) is lower than baseline anxiety (measured during the preoperative consultation using the VAS-A).

    Measured: Baseline (preoperative consultation) and Day 1 (preoperative assessment before surgery)

Secondary outcomes (1)
  1. Anxiety, quality of information, and disorientation during hospitalization and the ambulatory pathway

    Patients' perceived anxiety during hospitalization, measured using Likert-scale questionnaires.

    Patients' perceived quality of information, measured using Likert-scale questionnaires.

    Patients' reported feelings of disorientation and perception of information during the ambulatory pathway, measured using Likert-scale questionnaires.

    Measured: Day 1 (postoperative assessment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study start1 Oct 2024
  3. Primary completion9 Feb 2026
  4. Study completion9 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The primary objective of this research is to evaluate the effectiveness of a 360° video, presented in Virtual Reality, in enhancing patient information and reducing anxiety and disorientation among patients undergoing outpatient ophthalmology surgery, compared to a traditional 2D video and a baseline condition with no media intervention.
Masking
None (open label)
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07530120
Sponsor's protocol ID
IRB : IORG0011023
Acronym
OpeZen
Status last verified
Apr 2026
First submitted
9 Feb 2026
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The investigators have not yet decided whether individual participant data (IPD) from this study will be shared. If a decision is made not to share, it will be due to the sensitive nature of patient health information and the need to protect participant privacy.

Questions about this trial

What is this clinical trial studying?

A study testing Watching a video of the outpatient care pathway and No viewing of the video in people with Preoperative Anxiety and Virtual Reality, run by Institut Ophtalmologique de l'Ouest Jules Verne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients with reduced preoperative anxiety compared to baseline (time frame: Baseline (preoperative consultation) and Day 1 (preoperative assessment before surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in